Crossref
Nephroprotection in metabolic syndrome: from control of individual symptoms to systemic therapy
Nephrology · 23.06.2026 · 2_2026 · 87-92
DOI: 10.18565/nephrology.2026.2.87-92 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology, erschienen am 23.06.2026. Verfasst von Mikhailova L.V. Mikhailova und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mikhailova, M. L., Rafalsky, R. V., Kryukova, K. N., Tynterova, T. A., & Filimonkina, F. I. (2026). Nephroprotection in metabolic syndrome: from control of individual symptoms to systemic therapy. Nephrology, 2_2026, 87-92. https://doi.org/10.18565/nephrology.2026.2.87-92
Vancouver
Mikhailova ML, Rafalsky RV, Kryukova KN, Tynterova TA, Filimonkina FI. Nephroprotection in metabolic syndrome: from control of individual symptoms to systemic therapy. Nephrology. 2026;2_2026:87-92. doi:10.18565/nephrology.2026.2.87-92
BibTeX
@article{Mikhailova2026,
author = {Mikhailova, Mikhailova L.V. and Rafalsky, Rafalsky V.V. and Kryukova, Kryukova N.O. and Tynterova, Tynterova A.M. and Filimonkina, Filimonkina I.A.},
title = {Nephroprotection in metabolic syndrome: from control of individual symptoms to systemic therapy},
journal = {Nephrology},
year = {2026},
volume = {2_2026},
pages = {87--92},
doi = {10.18565/nephrology.2026.2.87-92}
}
EUVIMED